“`html<\/p>\n
\u0130nsan papilloma vir\u00fcs\u00fc, rahim a\u011fz\u0131 kanserlerinin neredeyse tamam\u0131ndan sorumlu ve vulva, vajen, an\u00fcs, penis veya orofarinks kanserleri gibi di\u011fer kanser t\u00fcrlerine de katk\u0131da bulunuyor. Bu vir\u00fcs\u00fcn baz\u0131 tiplerinin neden oldu\u011fu kal\u0131c\u0131 enfeksiyonlar, zamanla kanser \u00f6nc\u00fcs\u00fc lezyonlara yol a\u00e7abilir ve ard\u0131ndan invaziv kansere d\u00f6n\u00fc\u015febilir. \u0130spanya’da 16 numaral\u0131 tip en yayg\u0131n olan\u0131 ve rahim a\u011fz\u0131 kanserlerinin en az %58’inden sorumlu.<\/p>\n
Bu vir\u00fcse kar\u015f\u0131 bir a\u015f\u0131 bulunuyor ve en tehlikeli su\u015flar\u0131 hedef al\u0131yor. A\u015f\u0131, papilloma vir\u00fcs\u00fcne ba\u011fl\u0131 kanserlerin %90’\u0131na kadar\u0131n\u0131 \u00f6nleyebiliyor. Bununla birlikte, a\u015f\u0131 t\u00fcm kanserojen su\u015flara kar\u015f\u0131 koruma sa\u011flam\u0131yor ve zaten var olan enfeksiyonlar\u0131 tedavi etmiyor. Bu nedenle, a\u015f\u0131lanm\u0131\u015f ki\u015filer i\u00e7in bile tarama yapmak hala zorunlu.<\/p>\n
\u0130spanya’da gen\u00e7 k\u0131zlara y\u00f6nelik sistematik a\u015f\u0131lamaya 2008 y\u0131l\u0131nda ba\u015fland\u0131 ve 2022 y\u0131l\u0131ndan beri 12 ya\u015f\u0131ndaki erkekler de a\u015f\u0131 kapsam\u0131na al\u0131nd\u0131. Buna ra\u011fmen, a\u015f\u0131 kapsam\u0131, D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc’n\u00fcn belirledi\u011fi hedeflerin alt\u0131nda kalmaya devam ediyor ve b\u00f6lgeler aras\u0131nda \u00f6nemli farkl\u0131l\u0131klar var. Baz\u0131 b\u00f6lgelerde a\u015f\u0131 kapsam\u0131 ancak %20 iken, di\u011ferlerinde %80’in \u00fczerinde.<\/p>\n
Rahim a\u011fz\u0131 kanseri taramas\u0131, geleneksel y\u00f6ntemlerden daha hassas olan y\u00fcksek riskli su\u015flar\u0131 tespit eden testlere do\u011fru evriliyor. Ancak, uygulama b\u00f6lgeler aras\u0131nda e\u015fit olmayan bir \u015fekilde devam ediyor ve ulusal d\u00fczeyde veriler yeterince hassas de\u011fil. 25-65 ya\u015f aras\u0131 \u0130spanyol kad\u0131nlar\u0131n yakla\u015f\u0131k %87’si daha \u00f6nce tarama yapt\u0131rd\u0131\u011f\u0131n\u0131 beyan ediyor, ancak bu rakam \u00e7ok de\u011fi\u015fken ger\u00e7eklikleri gizliyor.<\/p>\n
2020 y\u0131l\u0131nda \u0130spanya, papilloma vir\u00fcs\u00fcne ba\u011fl\u0131 kanserler nedeniyle yakla\u015f\u0131k 2.000 \u00f6l\u00fcm kaydetti; bunlar\u0131n yar\u0131s\u0131 rahim a\u011fz\u0131 kanserine ait. An\u00fcs, orofarinks veya penis kanseri gibi di\u011fer kanserler de her y\u0131l tahmini 5.000’den fazla yeni vaka ile \u00f6nemli bir y\u00fck olu\u015fturuyor.<\/p>\n
Y\u00fcksek gelirli bir\u00e7ok \u00fclke, a\u015f\u0131 sayesinde papilloma vir\u00fcs\u00fc enfeksiyonlar\u0131, kanser \u00f6nc\u00fcs\u00fc lezyonlar ve rahim a\u011fz\u0131 kanserlerinde \u00f6nemli bir d\u00fc\u015f\u00fc\u015f g\u00f6zlemledi. \u00d6rne\u011fin, \u0130sve\u00e7’te 17 ya\u015f\u0131ndan \u00f6nce a\u015f\u0131lanm\u0131\u015f kad\u0131nlarda invaziv kanser riski %88 azald\u0131. \u0130ngiltere’de a\u015f\u0131, y\u00fczlerce kanser vakas\u0131n\u0131 ve binlerce kanser \u00f6nc\u00fcs\u00fc lezyonu \u00f6nlemeye yard\u0131mc\u0131 oldu.<\/p>\n
Buna ra\u011fmen, \u0130spanya’da bu kanserlerde kal\u0131c\u0131 ve net bir d\u00fc\u015f\u00fc\u015f hen\u00fcz g\u00f6zlenmedi. Bunun birka\u00e7 a\u00e7\u0131klamas\u0131 var: yetersiz a\u015f\u0131 kapsam\u0131, hala \u00e7ok e\u015fit olmayan tarama, anormal sonu\u00e7lardan sonra yetersiz takip ve eksik epidemiyolojik veriler. Ayr\u0131ca, yak\u0131n zamanda ba\u015flat\u0131lan erkeklerin a\u015f\u0131lamas\u0131n\u0131n etkisi hen\u00fcz \u00f6l\u00e7\u00fclemedi.<\/p>\n
Rahim a\u011fz\u0131 kanserinin geli\u015fim s\u00fcreci uzun; enfeksiyondan kanser ortaya \u00e7\u0131kmas\u0131na kadar genellikle on y\u0131ldan fazla s\u00fcre ge\u00e7iyor. Di\u011fer \u00fclkelerde g\u00f6zlemlenen azalmalar \u00f6nce enfeksiyonlar\u0131 ve kanser \u00f6nc\u00fcs\u00fc lezyonlar\u0131 kaps\u0131yor, ard\u0131ndan invaziv kanserlere ula\u015f\u0131l\u0131yor. \u0130spanya’da, koruma stratejilerinin uygulanmas\u0131 ile kanserler \u00fczerinde g\u00f6r\u00fcn\u00fcr etkilerin ortaya \u00e7\u0131kmas\u0131 aras\u0131nda ge\u00e7en s\u00fcre, bu nedenle hala birka\u00e7 y\u0131l daha s\u00fcrebilir.<\/p>\n
A\u015f\u0131 kapsam\u0131n\u0131 art\u0131rmak, taramay\u0131 standartla\u015ft\u0131rmak, hastalar\u0131n takibini g\u00fc\u00e7lendirmek ve ulusal d\u00fczeyde verileri daha iyi entegre etmek, bu kanserlerin azalt\u0131lmas\u0131n\u0131 h\u0131zland\u0131rmak i\u00e7in kilit ad\u0131mlar. Bu \u00f6nlemler olmadan, b\u00f6lgesel e\u015fitsizlikler ve koruma eksiklikleri devam etme riski ta\u015f\u0131yor.<\/p>\n
“`<\/p>\n
DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1007\/s12094-026-04447-w<\/a><\/p>\n Titre\u00a0:<\/strong> HPV-related cancer prevention in Spain: progress and remaining challenges in vaccination, screening, and surveillance<\/p>\n Revue : <\/strong> Clinical and Translational Oncology<\/p>\n \u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n Auteurs : <\/strong> Alejandro Gallego Mart\u00ednez; Antonio Gonzalez-Martin; Luis Chiva de Agustin<\/p>\n","protected":false},"excerpt":{"rendered":" “`html \u0130nsan papilloma vir\u00fcs\u00fcne ba\u011fl\u0131 kanserle m\u00fccadelede a\u015f\u0131 ve tarama, \u0130spanya’da tam etkisini g\u00f6stermekte zorlan\u0131yor \u0130nsan papilloma vir\u00fcs\u00fc, rahim a\u011fz\u0131 kanserlerinin neredeyse tamam\u0131ndan sorumlu ve vulva, vajen, an\u00fcs, penis veya orofarinks kanserleri gibi di\u011fer kanser t\u00fcrlerine de katk\u0131da bulunuyor. Bu vir\u00fcs\u00fcn baz\u0131 tiplerinin neden oldu\u011fu kal\u0131c\u0131 enfeksiyonlar, zamanla kanser \u00f6nc\u00fcs\u00fc lezyonlara yol a\u00e7abilir ve ard\u0131ndan… Okumaya devam et \u0130nsan papilloma vir\u00fcs\u00fcne ba\u011fl\u0131 kanserle m\u00fccadelede a\u015f\u0131 ve tarama, \u0130spanya’da tam etkisini g\u00f6stermekte zorlan\u0131yor<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,4,6],"tags":[],"class_list":["post-25","post","type-post","status-publish","format-standard","hentry","category-insan-insani","category-saglik","category-toplum","entry"],"_links":{"self":[{"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/posts\/25","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/comments?post=25"}],"version-history":[{"count":1,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/posts\/25\/revisions"}],"predecessor-version":[{"id":26,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/posts\/25\/revisions\/26"}],"wp:attachment":[{"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/media?parent=25"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/categories?post=25"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/internationalsciencereview.com\/tr\/wp-json\/wp\/v2\/tags?post=25"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}